Pfizer Inc
NYSE:PFE
Pfizer Inc
Selling, General & Administrative
Pfizer Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pfizer Inc
NYSE:PFE
|
Selling, General & Administrative
-$14.5B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
Johnson & Johnson
NYSE:JNJ
|
Selling, General & Administrative
-$21.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Selling, General & Administrative
-$7.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
Merck & Co Inc
NYSE:MRK
|
Selling, General & Administrative
-$10.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Zoetis Inc
NYSE:ZTS
|
Selling, General & Administrative
-$2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Selling, General & Administrative
-$7.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
See Also
What is Pfizer Inc's Selling, General & Administrative?
Selling, General & Administrative
-14.5B
USD
Based on the financial report for Mar 31, 2024, Pfizer Inc's Selling, General & Administrative amounts to -14.5B USD.
What is Pfizer Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
0%
Over the last year, the Selling, General & Administrative growth was 4%. The average annual Selling, General & Administrative growth rates for Pfizer Inc have been -76% over the past three years .